These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2427060)

  • 1. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma.
    Cantaboni A; Sironi M; Taccagni GL; Ferrari AM
    Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
    Ferrandez-Izquierdo A; Llombart-Bosch A
    Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in Israel: relationship to hepatitis B virus infection.
    Yahalom J; Livni N; Fuks Z; Levij IS
    Isr J Med Sci; 1985 Jan; 21(1):1-5. PubMed ID: 2579047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical study on HBsAg, HBcAg and AFP in 104 patients with small liver cancer].
    Zhang SP
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):353-6. PubMed ID: 2470564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical studies in hepatocarcinomas].
    Delfino MI; De Marco L; Simian S; Avagnina A; Elsner B
    Medicina (B Aires); 1985; 45(3):235-9. PubMed ID: 2429135
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of five antigens in hepatocellular carcinoma.
    Thung SN; Gerber MA; Sarno E; Popper H
    Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
    Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
    Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
    Cohen C; Derose PB
    Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of hepatocellular carcinoma as viewed by the pathologist.
    Callea F
    Appl Pathol; 1988; 6(2):105-16. PubMed ID: 2839213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular dysplasia: immunohistochemical and morphometrical evaluation.
    Pollice L; Ricco R; Russo S; Maiorano E; Pagniello G; Delfino-Pesce V
    Appl Pathol; 1988; 6(2):73-81. PubMed ID: 2455530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
    Swenson PD; Escobar MR; Silverman JF
    Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
    McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
    Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
    Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent studies on the developing human hepatocellular carcinoma.
    Gerber MA
    Cancer Surv; 1986; 5(4):741-63. PubMed ID: 2441863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.